Sertraline tablets recalled because bottle seals are not adhering
Lupin Pharmaceuticals is recalling 52,128 bottles of Sertraline Hydrochloride Tablets, 100 mg, over a defective container in which the seal is not adhering to the bottles.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 because the record cites a container seal defect with no stated clinical consequence or reported harm.
Plain-English summary
Sertraline Hydrochloride Tablets USP, 100 mg, in 90-tablet bottles, manufactured by Lupin Pharmaceuticals, Inc. of Naples, Florida, under NDC 68180-353-09, are being recalled.
The reason given in the enforcement record is a defective container: the seal is not adhering to the bottles.
The recall covers 52,128 bottles from lot QB00865, expiry February 2028. Distribution was nationwide. The FDA has classified the action as Class II.
Patients should not stop taking a prescribed medicine without speaking to their prescriber or pharmacist, who can confirm whether a specific bottle is affected and arrange a replacement.
The recalled product
- Product
- SERTRALINE HYDROCHLORIDE (SERTRALINE HYDROCHLORIDE)
- Brand
- SERTRALINE HYDROCHLORIDE
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Category
- Drug — Antidepressant
- Affected units
- 52,128
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # QB00865
- exp. date Feb 2028
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SERTRALINE HYDROCHLORIDE
- HighSertraline Hydrochloride Tablets Recalled Due to Manufacturing Process Defect
FDA (Drugs) · 2024-01-03
Same manufacturer · Lupin Pharmaceuticals Inc.
See all →- ModerateLupin Recalls Clobetasol Propionate Cream for Content Uniformity Failures
FDA (Drugs) · 2026-09-02
- SevereGlucagon Emergency Kit Recalled for Manufacturing Process Deviation
FDA (Drugs) · 2026-07-08
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- ModerateGanirelix acetate injection recalled after failing an impurity specification
FDA (Drugs) · 2025-12-17
Same hazard · defective container
See all →- High
- ModeratePureLife benzocaine topical anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModerateBurkhart benzocaine topical anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModeratePearson Quality benzocaine anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModerateDental City benzocaine anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24